Urinary kidney stone inhibitors. Where are we?
Dussol
B
B
Berland
Y
Y
D002129:Calcium Oxalate / Q000037:antagonists & inhibitors / Q000378:metabolism; D002135:Calcium-Binding Proteins / Q000378:metabolism; D006023:Glycoproteins / Q000378:metabolism; D006025:Glycosaminoglycans / Q000378:metabolism; D006801:Humans; D051847:Lithostathine; D008562:Membrane Glycoproteins; D009088:Mucoproteins / Q000378:metabolism; D009397:Nephrocalcinosis / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control*; D009419:Nerve Tissue Proteins; D053495:Osteopontin; D011506:Proteins / Q000378:metabolism; D014360:Trypsin Inhibitor, Kunitz Soybean; D058949:Uromodulin
D002135:Calcium-Binding Proteins; D006023:Glycoproteins; D006025:Glycosaminoglycans; D051847:Lithostathine; D008562:Membrane Glycoproteins; D009088:Mucoproteins; D009419:Nerve Tissue Proteins; D011506:Proteins; C497617:REG1A protein, human; C109148:SPINT2 protein, human; C548612:UMOD protein, human; D058949:Uromodulin; C083359:crystal matrix protein, human; C029490:nephrocalcin; D053495:Osteopontin; D002129:Calcium Oxalate; D014360:Trypsin Inhibitor, Kunitz Soybean